Treatments to Promote Neural Repair after Stroke

키워드

참고문헌 (180)

1. Johnston SC, "Neurological disease on the global agenda", Ann Neurol, 64, pp.A11~A12 (2008)
2. Writing Group Members, "Heart disease and stroke statistics-2016 update: a report from the American Heart Association", Circulation, 133, pp.e38~e360 (2016)[DOI]
3. WRITING GROUP MEMBERS, "Heart disease and stroke statistics: 2010 update: a report from the American Heart Association", Circulation, 121, pp.e46~e215 (2010)[DOI]
4. Hacke W, "Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke", N Engl J Med, 359, pp.1317~1329 (2008)[DOI]
5. National Institute of Neurological Disorders, "Tissue plasminogen activator for acute ischemic stroke", N Engl J Med, 333, pp.1581~1587 (1995)[DOI]
6. Reed SD, "Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals", Stroke, 32, pp.1832~1840 (2001)[DOI]
7. Adeoye O, "Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years", Stroke, 42, pp.1952~1955 (2011)[DOI]
8. Goyal M, "Endovascular thrombectomy after largevessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials", Lancet, 387, pp.1723~1731 (2016)[DOI]
9. Overman JJ, "Plasticity in the injured brain: more than molecules matter", Neuroscientist, 20, pp.15~28 (2014)[DOI]
10. Cramer SC, "Recovery recapitulates ontogeny", Trends Neurosci, 23, pp.265~271 (2000)[DOI]
11. Wieloch T, "Mechanisms of neural plasticity following brain injury", Curr Opin Neurobiol, 16, pp.258~264 (2006)[DOI]
12. Nudo RJ, "Neural bases of recovery after brain injury", J Commun Disord, 44, pp.515~520 (2011)[DOI]
13. Li S, "Growth-associated gene and protein expression in the region of axonal sprouting in the aged brain after stroke", Neurobiol Dis, 23, pp.362~373 (2006)[DOI]
14. Arai K, "Experimental models for analysis of oligodendrocyte pathophysiology in stroke", Exp Transl Stroke Med, 1, pp.6~ (2009)[DOI]
15. Zhang ZG, "Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic", Lancet Neurol, 8, pp.491~500 (2009)[DOI]
16. Carmichael ST, "Cellular and molecular mechanisms of neural repair after stroke: making waves", Ann Neurol, 59, pp.735~742 (2006)[DOI]
17. Murphy TH, "Plasticity during stroke recovery: from synapse to behaviour", Nat Rev Neurosci, 10, pp.861~872 (2009)[DOI]
18. Finklestein SP, "Growth factor expression after stroke", Stroke, 21(11 Suppl), pp.III122~III124 (1990)
19. Kawamata T, "Brain Plasticity Advances in Neurology. Vol. 73", pp.377~382 (1997), Lippincott-Raven
20. Jones TA, "Synaptogenesis and dendritic growth in the cortex opposite unilateral sensorimotor cortex damage in adult rats: a quantitative electron microscopic examination", Brain Res, 733, pp.142~148 (1996)[DOI]
21. Jones TA, "Overgrowth and pruning of dendrites in adult rats recovering from neocortical damage", Brain Res, 581, pp.156~160 (1992)[DOI]
22. Ding G, "Magnetic resonance imaging investigation of axonal remodeling and angiogenesis after embolic stroke in sildenafiltreated rats", J Cereb Blood Flow Metab, 28, pp.1440~1448 (2008)[DOI]
23. Seevinck PR, "Magnetic resonance imaging of brain angiogenesis after stroke", Angiogenesis, 13, pp.101~111 (2010)[DOI]
24. Teng H, "Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke", J Cereb Blood Flow Metab, 28, pp.764~771 (2008)[DOI]
25. Hermann DM, "Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation", Lancet Neurol, 11, pp.369~380 (2012)[DOI]
26. Redecker C, "Widespread and long-lasting alterations in GABA(A)-receptor subtypes after focal cortical infarcts in rats: mediation by NMDA-dependent processes", J Cereb Blood Flow Metab, 22, pp.1463~1475 (2002)[DOI]
27. Clarkson AN, "AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke", J Neurosci, 31, pp.3766~3775 (2011)[DOI]
28. Clarkson AN, "Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke", Nature, 468, pp.305~309 (2010)[DOI]
29. Que M, "Widespread up-regulation of N-methyl-D-aspartate receptors after focal photothrombotic lesion in rat brain", Neurosci Lett, 273, pp.77~80 (1999)[DOI]
30. Kawamata T, "Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction", Proc Natl Acad Sci U S A, 94, pp.8179~8184 (1997)[DOI]
31. Dijkhuizen RM, "Functional MRI and diffusion tensor imaging of brain reorganization after experimental stroke", Transl Stroke Res, 3, pp.36~43 (2012)[DOI]
32. Dancause N, "Extensive cortical rewiring after brain injury", J Neurosci, 25, pp.10167~10179 (2005)[DOI]
33. Sist B, "Plasticity beyond peri-infarct cortex: spinal up regulation of structural plasticity, neurotrophins, and inflammatory cytokines during recovery from cortical stroke", Exp Neurol, 252, pp.47~56 (2014)[DOI]
34. Cramer SC, "Repairing the human brain after stroke: I. mechanisms of spontaneous recovery", Ann Neurol, 63, pp.272~287 (2008)[DOI]
35. Ren J, "Time window of intracisternal osteogenic protein-1 in enhancing functional recovery after stroke", Neuropharmacology, 39, pp.860~865 (2000)[DOI]
36. Nouri S, "Anatomy and physiology predict response to motor cortex stimulation after stroke", Neurology, 77, pp.1076~1083 (2011)[DOI]
37. Duering M, "Incident subcortical infarcts induce focal thinning in connected cortical regions", Neurology, 79, pp.2025~2028 (2012)[DOI]
38. Duering M, "Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts", Neurology, 84, pp.1685~1692 (2015)[DOI]
39. Gauthier LV, "Atrophy of spared gray matter tissue predicts poorer motor recovery and rehabilitation response in chronic stroke", Stroke, 43, pp.453~457 (2012)[DOI]
40. Grefkes C, "Cortical reorganization after stroke: how much and how functional?", Neuroscientist, 20, pp.56~70 (2014)[DOI]
41. Stinear CM, "An update on predicting motor recovery after stroke", Ann Phys Rehabil Med, 57, pp.489~498 (2014)[DOI]
42. Cassidy JM, "Spontaneous and therapeutic-induced mechanisms of functional recovery after stroke", Transl Stroke Res, 8, pp.33~46 (2017)[DOI]
43. Lotze M, "The role of multiple contralesional motor areas for complex hand movements after internal capsular lesion", J Neurosci, 26, pp.6096~6102 (2006)[DOI]
44. Johansen-Berg H, "Correlation between motor improvements and altered fMRI activity after rehabilitative therapy", Brain, 125, pp.2731~2742 (2002)[DOI]
45. Bradnam LV, "Contralesional hemisphere control of the proximal paretic upper limb following stroke", Cereb Cortex, 22, pp.2662~2671 (2012)[DOI]
46. Netz J, "Reorganization of motor output in the non-affected hemisphere after stroke", Brain, 120, pp.1579~1586 (1997)[DOI]
47. Turton A, "Contralateral and ipsilateral EMG responses to transcranial magnetic stimulation during recovery of arm and hand function after stroke", Electroencephalogr Clin Neurophysiol, 101, pp.316~328 (1996)[DOI]
48. Heiss WD, "A proposed regional hierarchy in recovery of post-stroke aphasia", Brain Lang, 98, pp.118~123 (2006)[DOI]
49. Ward NS, "Neural correlates of motor recovery after stroke: a longitudinal fMRI study", Brain, 126, pp.2476~2496 (2003)[DOI]
50. Cramer SC, "Repairing the human brain after stroke. II. Restorative therapies", Ann Neurol, 63, pp.549~560 (2008)[DOI]
51. Cumberland Consensus Working Group, "The future of restorative neurosciences in stroke: driving the translational research pipeline from basic science to rehabilitation of people after stroke", Neurorehabil Neural Repair, 23, pp.97~107 (2009)[DOI]
52. Knecht S, "Rehabilitation after stroke", Dtsch Arztebl Int, 108, pp.600~606 (2011)
53. Lanfranconi S, "Growth factors in ischemic stroke", J Cell Mol Med, 15, pp.1645~1687 (2011)[DOI]
54. Oliveira SL, "Functions of neurotrophins and growth factors in neurogenesis and brain repair", Cytometry A, 83, pp.76~89 (2013)
55. Ren JM, "Growth factor treatment of stroke", Curr Drug Targets CNS Neurol Disord, 4, pp.121~125 (2005)[DOI]
56. Kolb B, "Growth factor-stimulated generation of new cortical tissue and functional recovery after stroke damage to the motor cortex of rats", J Cereb Blood Flow Metab, 27, pp.983~997 (2007)[DOI]
57. Belayev L, "A novel neurotrophic therapeutic strategy for experimental stroke", Brain Res, 1280, pp.117~123 (2009)[DOI]
58. Schabitz WR, "AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke", Stroke, 41, pp.2545~2551 (2010)[DOI]
59. England TJ, "Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial", Stroke, 43, pp.405~411 (2012)[DOI]
60. Ringelstein EB, "Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial", Stroke, 44, pp.2681~2687 (2013)[DOI]
61. England TJ, "Granulocyte-colony stimulating factor (G-CSF) for stroke: an individual patient data meta-analysis", Sci Rep, 6, pp.36567~ (2016)[DOI]
62. Jerndal M, "A systematic review and meta-analysis of erythropoietin in experimental stroke", J Cereb Blood Flow Metab, 30, pp.961~968 (2010)[DOI]
63. Yip HK, "Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke", Crit Care, 15, pp.R40~ (2011)[DOI]
64. Cramer SC, "The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial", Stroke, 41, pp.927~931 (2010)[DOI]
65. Cramer SC, "Human choriogonadotropin and epoetin alfa in acute ischemic stroke patients (REGENESIS-LED trial)", Int J Stroke, 9, pp.321~327 (2014)[DOI]
66. Ehrenreich H, "Recombinant human erythropoietin in the treatment of acute ischemic stroke", Stroke, 40, pp.e647~e656 (2009)[DOI]
67. Zhang Y, "Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion", Brain Res, 1111, pp.227~229 (2006)[DOI]
68. Kim BO, "Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model", Circulation, 112(9 Suppl), pp.I96~I104 (2005)[DOI]
69. Horita Y, "Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat", J Neurosci Res, 84, pp.1495~1504 (2006)[DOI]
70. Zhao LX, "Modification of the brain-derived neurotrophic factor gene: a portal to transform mesenchymal stem cells into advantageous engineering cells for neuroregeneration and neuroprotection", Exp Neurol, 190, pp.396~406 (2004)[DOI]
71. Iwase T, "Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia", Cardiovasc Res, 66, pp.543~551 (2005)[DOI]
72. Liu H, "Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia", Brain, 129, pp.2734~2745 (2006)[DOI]
73. Zhao MZ, "Novel therapeutic strategy for stroke in rats by bone marrow stromal cells and ex vivo HGF gene transfer with HSV-1 vector", J Cereb Blood Flow Metab, 26, pp.1176~1188 (2006)[DOI]
74. Hermann DM, "Enhancing the delivery of erythropoietin and its variants into the ischemic brain", ScientificWorldJournal, 9, pp.967~969 (2009)[DOI]
75. Zhang Y, "Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin", Brain Res, 889, pp.49~56 (2001)[DOI]
76. Yasuhara T, "Ex vivo gene therapy: transplantation of neurotrophic factor-secreting cells for cerebral ischemia", Front Biosci, 11, pp.760~775 (2006)[DOI]
77. Wattananit S, "Monocyte-derived macrophages contribute to spontaneous long-term functional recovery after stroke in mice", J Neurosci, 36, pp.4182~4195 (2016)[DOI]
78. Ziv Y, "Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood", Nat Neurosci, 9, pp.268~275 (2006)[DOI]
79. Rivers WH, "A human experiment in nerve division", Brain, 31, pp.323~450 (1908)[DOI]
80. Cheatwood JL, "Nogo-A expression after focal ischemic stroke in the adult rat", Stroke, 39, pp.2091~2098 (2008)[DOI]
81. Domeniconi M, "Overcoming inhibitors in myelin to promote axonal regeneration", J Neurol Sci, 233, pp.43~47 (2005)[DOI]
82. Buchli AD, "Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system", Ann Med, 37, pp.556~567 (2005)[DOI]
83. Cramer SC, "Safety, pharmacokinetics, and pharmacodynamics of escalating repeat doses of GSK249320 in patients with stroke", Stroke, 44, pp.1337~1342 (2013)[DOI]
84. Cramer SC, "Proof-of-concept randomized trial of the monoclonal antibody GSK249320 versus placebo in stroke patients", Stroke, 48, pp.692~698 (2017)[DOI]
85. Pardridge WM, "Drug transport across the blood-brain barrier", J Cereb Blood Flow Metab, 32, pp.1959~1972 (2012)[DOI]
86. Feeney DM, "Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury", Science, 217, pp.855~857 (1982)[DOI]
87. Crisostomo EA, "Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients", Ann Neurol, 23, pp.94~97 (1988)[DOI]
88. Walker-Batson D, "Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence", Stroke, 26, pp.2254~2259 (1995)[DOI]
89. Gladstone DJ, "Physiotherapy coupled with dextroamphetamine for rehabilitation after hemiparetic stroke: a randomized, double-blind, placebo-controlled trial", Stroke, 37, pp.179~185 (2006)[DOI]
90. Tritsch NX, "Dopaminergic modulation of synaptic transmission in cortex and striatum", Neuron, 76, pp.33~50 (2012)[DOI]
91. McAllister TW, "Polymorphisms in genes modulating the dopamine system: do they inf luence outcome and response to medication after traumatic brain injury?", J Head Trauma Rehabil, 24, pp.65~68 (2009)[DOI]
92. Molina-Luna K, "Dopamine in motor cortex is necessary for skill learning and synaptic plasticity", PLoS One, 4, pp.e7082~ (2009)[DOI]
93. Hosp JA, "Dopaminergic projections from midbrain to primary motor cortex mediate motor skill learning", J Neurosci, 31, pp.2481~2487 (2011)[DOI]
94. Floel A, "Recovery of function in humans: cortical stimulation and pharmacological treatments after stroke", Neurobiol Dis, 37, pp.243~251 (2010)[DOI]
95. Scheidtmann K, "Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, doubleblind study", Lancet, 358, pp.787~790 (2001)[DOI]
96. Pearson-Fuhrhop KM, "Genetic variation in the human brain dopamine system influences motor learning and its modulation by LDopa", PLoS One, 8, pp.e61197~ (2013)[DOI]
97. MacDonald HJ, "Dopamine gene profiling to predict impulse control and effects of dopamine agonist ropinirole", J Cogn Neurosci, 28, pp.909~919 (2016)[DOI]
98. Cramer SC, "Randomized, placebo-controlled, double-blind study of ropinirole in chronic stroke", Stroke, 40, pp.3034~3038 (2009)[DOI]
99. Small SL, "Biological approaches to aphasia treatment", Curr Neurol Neurosci Rep, 9, pp.443~450 (2009)[DOI]
100. Wang LE, "Noradrenergic enhancement improves motor network connectivity in stroke patients", Ann Neurol, 69, pp.375~388 (2011)[DOI]
101. Fasotti L, "Novel insights in the rehabilitation of neglect", Front Hum Neurosci, 7, pp.780~ (2013)
102. Cools R, "Serotoninergic regulation of emotional and behavioural control processes", Trends Cogn Sci, 12, pp.31~40 (2008)[DOI]
103. Logue SF, "The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition", Pharmacol Biochem Behav, 123, pp.45~54 (2014)[DOI]
104. Cowen P, "The role of serotonin in cognitive function: evidence from recent studies and implications for understanding depression", J Psychopharmacol, 27, pp.575~583 (2013)[DOI]
105. Dam M, "Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy", Stroke, 27, pp.1211~1214 (1996)[DOI]
106. Miyai I, "Effects of antidepressants on functional recovery following stroke: a double-blind study", Neurorehabil Neural Repair, 12, pp.5~13 (1998)[DOI]
107. Pariente J, "Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke", Ann Neurol, 50, pp.718~729 (2001)[DOI]
108. Fruehwald S, "Early fluoxetine treatment of post-stroke depression: a threemonth double-blind placebo-controlled study with an openlabel long-term follow up", J Neurol, 250, pp.347~351 (2003)[DOI]
109. Robinson RG, "Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial", JAMA, 299, pp.2391~2400 (2008)[DOI]
110. Mikami K, "Prevention of post-stroke generalized anxiety disorder, using escitalopram or problem-solving therapy", J Neuropsychiatry Clin Neurosci, 26, pp.323~328 (2014)[DOI]
111. Chollet F, "Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial", Lancet Neurol, 10, pp.123~130 (2011)[DOI]
112. Kato M, "Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder", Mol Psychiatry, 15, pp.473~500 (2010)[DOI]
113. Kohen R, "Response to psychosocial treatment in poststroke depression is associated with serotonin transporter polymorphisms", Stroke, 42, pp.2068~2070 (2011)[DOI]
114. Kim JS, "Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebocontrolled study", Lancet Psychiatry, 4, pp.33~41 (2017)[DOI]
115. Merzenich MM, "Brain plasticitybased therapeutics", Front Hum Neurosci, 8, pp.385~ (2014)
116. Beltran EJ, "Long-term motor improvement after stroke is enhanced by short-term treatment with the alpha-2 antagonist, atipamezole", Brain Res, 1346, pp.174~182 (2010)[DOI]
117. Zittel S, "Reboxetine improves motor function in chronic stroke. A pilot study", J Neurol, 254, pp.197~201 (2007)[DOI]
118. Baskerville KA, "Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat", Neuroscience, 80, pp.1159~1169 (1997)[DOI]
119. Luria AR, "Restoration of Function after Brain Injury" (1963), Macmillan
120. Kilgard MP, "Cortical map reorganization enabled by nucleus basalis activity", Science, 279, pp.1714~1718 (1998)[DOI]
121. Wang L, "Rehabilitation drives enhancement of neuronal structure in functionally relevant neuronal subsets", Proc Natl Acad Sci U S A, 113, pp.2750~2755 (2016)[DOI]
122. Ramanathan D, "The basal forebrain cholinergic system is required specifically for behaviorally mediated cortical map plasticity", J Neurosci, 29, pp.5992~6000 (2009)[DOI]
123. Berthier ML, "A randomized, placebo-controlled study of donepezil in poststroke aphasia", Neurology, 67, pp.1687~1689 (2006)[DOI]
124. Barrett KM, "Enhancing recovery after acute ischemic stroke with donepezil as an adjuvant therapy to standard medical care: results of a phase IIA clinical trial", J Stroke Cerebrovasc Dis, 20, pp.177~182 (2011)[DOI]
125. Nadeau SE, "Donepezil as an adjuvant to constraint-induced therapy for upper-limb dysfunction after stroke: an exploratory randomized clinical trial", J Rehabil Res Dev, 41, pp.525~534 (2004)[DOI]
126. Whyte EM, "An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients", Cerebrovasc Dis, 26, pp.317~321 (2008)[DOI]
127. Lopez-Valdes HE, "Memantine enhances recovery from stroke", Stroke, 45, pp.2093~2100 (2014)[DOI]
128. Zhang R, "Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats", Stroke, 33, pp.2675~2680 (2002)[DOI]
129. Bednar MM, "The role of sildenafil in the treatment of stroke", Curr Opin Investig Drugs, 9, pp.754~759 (2008)
130. Silver B, "Sildenafil treatment of subacute ischemic stroke: a safety study at 25-mg daily for 2 weeks", J Stroke Cerebrovasc Dis, 18, pp.381~383 (2009)[DOI]
131. Lindvall O, "Stem cell research in stroke: how far from the clinic?", Stroke, 42, pp.2369~2375 (2011)[DOI]
132. Savitz SI, "Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials", Stroke, 45, pp.634~639 (2014)[DOI]
133. Eckert MA, "Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke", J Cereb Blood Flow Metab, 33, pp.1322~1334 (2013)[DOI]
134. Li Y, "Marrow stromal cell transplantation in stroke and traumatic brain injury", Neurosci Lett, 456, pp.120~123 (2009)[DOI]
135. Phinney DG, "Concise review: mesenchymal stem", multipotent stromal cells: the state of transdifferentiation and modes of tissue repair: current views, 2007, pp.25, 2896~2902
136. Honmou O, "Mesenchymal stem cells: therapeutic outlook for stroke", Trends Mol Med, 18, pp.292~297 (2012)[DOI]
137. Vu Q, "Meta-analysis of preclinical studies of mesenchymal stromal cells for ischemic stroke", Neurology, 82, pp.1277~1286 (2014)[DOI]
138. Bang OY, "Autologous mesenchymal stem cell transplantation in stroke patients", Ann Neurol, 57, pp.874~882 (2005)[DOI]
139. Yavagal DR, "Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model", PLoS One, 9, pp.e93735~ (2014)[DOI]
140. Kalladka D, "Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study", Lancet, 388, pp.787~796 (2016)[DOI]
141. Steinberg GK, "Clinical outcomes of transplanted modified bone marrow-derived mesenchymal stem cells in stroke: a phase 1", 2a study, 2016, pp.47, 1817~1824
142. Hess DC, "Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial", Lancet Neurol, 16, pp.360~368 (2017)[DOI]
143. Hyun I, "The bioethics of stem cell research and therapy", J Clin Invest, 120, pp.71~75 (2010)[DOI]
144. Wolf SL, "Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial", JAMA, 296, pp.2095~2104 (2006)[DOI]
145. Wolf SL, "Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trial", Lancet Neurol, 7, pp.33~40 (2008)[DOI]
146. Berthier ML, "Neuroscience insights improve neurorehabilitation of poststroke aphasia", Nat Rev Neurol, 7, pp.86~97 (2011)[DOI]
147. Dromerick AW, "Very Early Constraint-Induced Movement Therapy (VECTORS): phase II trial results", Stroke, 38, pp.465~ (2007)
148. Duncan PW, "Body-weight-supported treadmill rehabilitation after stroke", N Engl J Med, 364, pp.2026~2036 (2011)[DOI]
149. Winstein CJ, "Effect of a task-oriented rehabilitation program on upper extremity recovery following motor stroke: the ICARE randomized clinical trial", JAMA, 315, pp.571~581 (2016)[DOI]
150. Lang CE, "Dose response of task-specific upper limb training in people at least 6 months poststroke: a phase II, singleblind, randomized, controlled trial", Ann Neurol, 80, pp.342~354 (2016)[DOI]
151. Brewer BR, "Poststroke upper extremity rehabilitation: a review of robotic systems and clinical results", Top Stroke Rehabil, 14, pp.22~44 (2007)[DOI]
152. Volpe BT, "Robotic devices as therapeutic and diagnostic tools for stroke recovery", Arch Neurol, 66, pp.1086~1090 (2009)
153. Reinkensmeyer DJ, "Robotics, motor learning, and neurologic recovery", Annu Rev Biomed Eng, 6, pp.497~525 (2004)[DOI]
154. Balasubramanian S, "Robot-assisted rehabilitation of hand function", Curr Opin Neurol, 23, pp.661~670 (2010)[DOI]
155. Veerbeek JM, "Effects of robot-assisted therapy for the upper limb after stroke", Neurorehabil Neural Repair, 31, pp.107~121 (2017)[DOI]
156. Cramer SC, "Brain repair after stroke", N Engl J Med, 362, pp.1827~1829 (2010)[DOI]
157. Lo AC, "Robot-assisted therapy for long-term upper-limb impairment after stroke", N Engl J Med, 362, pp.1772~1783 (2010)[DOI]
158. Dobkin BH, "A rehabilitation-internet-of-things in the home to augment motor skills and exercise training", Neurorehabil Neural Repair, 31, pp.217~227 (2017)[DOI]
159. Chen J, "Telerehabilitation approaches for stroke patients: systematic review and meta-analysis of randomized controlled trials", J Stroke Cerebrovasc Dis, 24, pp.2660~2668 (2015)[DOI]
160. Levy CE, "Effects of physical therapy delivery via home video telerehabilitation on functional and health-related quality of life outcomes", J Rehabil Res Dev, 52, pp.361~370 (2015)[DOI]
161. Choi YH, "A telerehabilitation approach for chronic aphasia following stroke", Telemed J E Health, 22, pp.434~440 (2016)[DOI]
162. Putrino D, "Telerehabilitation and emerging virtual reality approaches to stroke rehabilitation", Curr Opin Neurol, 27, pp.631~636 (2014)[DOI]
163. Agostini M, "Telerehabilitation and recovery of motor function: a systematic review and meta-analysis", J Telemed Telecare, 21, pp.202~213 (2015)[DOI]
164. Dodakian L, "A home-based telerehabilitation program for patients with stroke", Neurorehabil Neural Repair, 31, pp.923~933 (2017)[DOI]
165. "Telerehabilitation in the Home versus therapy in-clinic for patients with stroke" (2015)[URL]
166. Edwardson MA, "New modalities of brain stimulation for stroke rehabilitation", Exp Brain Res, 224, pp.335~358 (2013)[DOI]
167. Dawson J, "Safety, feasibility, and efficacy of vagus nerve stimulation paired with upper-limb rehabilitation after ischemic stroke", Stroke, 47, pp.143~150 (2016)[DOI]
168. American Psychiatric Association, "Practice Guideline for the Treatment of Patients with Major Depressive Disorder", American Psychiatric Association, ~ (2010)
169. McClintock SM, "Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression", J Clin Psychiatry (2017)
170. Lindenberg R, "Predicting functional motor potential in chronic stroke patients using diffusion tensor imaging", Hum Brain Mapp, 33, pp.1040~1051 (2012)[DOI]
171. Ackerley SJ, "Combining theta burst stimulation with training after subcortical stroke", Stroke, 41, pp.1568~1572 (2010)[DOI]
172. Levy R, "Cortical stimulation for upper-extremity hemiparesis from ischemic stroke: everest study primary endpoint results", International Stroke Conference 2008 (2008)
173. Pomeroy VM, "Transcranial magnetic stimulation and muscle contraction to enhance stroke recovery: a randomized proof-of-principle and feasibility investigation", Neurorehabil Neural Repair, 21, pp.509~517 (2007)[DOI]
174. Levy RM, "Epidural electrical stimulation for stroke rehabilitation: results of the prospective, multicenter, randomized, single-blinded everest trial", Neurorehabil Neural Repair, 30, pp.107~119 (2016)[DOI]
175. Kleim JA, "Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage", J Speech Lang Hear Res, 51, pp.S225~S239 (2008)[DOI]
176. Cramer SC, "Harnessing neuroplasticity for clinical applications", Brain, 134, pp.1591~1609 (2011)[DOI]
177. Cramer SC, "An overview of therapies to promote repair of the brain after stroke", Head Neck, 33(Suppl 1), pp.S5~S7 (2011)[DOI]
178. Bernhardt J, "Moving rehabilitation research forward: developing consensus statements for rehabilitation and recovery research", Neurorehabil Neural Repair, 31, pp.694~698 (2017)[DOI]
179. Bernhardt J, "Agreed definitions and a shared vision for new standards in stroke recovery research: the Stroke Recovery and Rehabilitation Roundtable taskforce", Int J Stroke, 12, pp.444~450 (2017)[DOI]
180. Cramer SC, "Stroke recovery and rehabilitation research: issues, opportunities, and the National Institutes of Health StrokeNet", Stroke, 48, pp.813~819 (2017)[DOI]

관련 논문AI추천